AlcoScan AL2500 Breathalyzer Available in Silver and Black. The AlcoScan AL2500 is a convenient, easy-to-use breathalyzer that is operated by blowing sharply into a sensor located on the face of the device. The AlcoScan AL2500 combines the quality of a professional grade device with the convenience of ultra-light portability and simplicity. With single-button operation, a bright 3-digit LCD display and no need for mouthpieces, the AL2500 is the easiest way to get quality results on the go. The AlcoScan AL2500 breathalyzer is a good choice for consumers who would maximum convenience and portability. The AL2500 does not use mouthpieces, so just the single breathalyzer is all you ever need to test yourself anytime, anywhere! The AlcoScan AL2500 shares all features with the AL2500 Elite except that it does not use mouthpieces for maximum ease-of-use. AlcoScan AL2500 Features DOT Approved for Law Enforcement: Accuracy +/-0.01 at 0.10%BAC US Coast Guard Approved 3-Digit LED Results Display Low Battery Indicator / Auto Power-Off No Mouthpieces Necessary
DESCRIPTION: Apple APP iOS Android 4.3 with Bluetooth4.0 European Fuel cell sensor Bluetooth for wireless Replaceable mouthpiece 1 pcs AAA battery (500 tests) Size: 80x50x18mm Display: 0.00-4.00â?° (2.00mg/L) Accuracy: +/- 0.05â?° at 0.50â?° (APP on Smartphone) Alcohol limit/unit selectable Recall tested memory
Lifeguard Personal Breath Alcohol Tester There is no more accurate personal alcohol tester available than the LifeGuard. Wherever and whenever there is the need for personal breath alcohol content (BAC) measurement, LifeGuard is the one to trust. Lifeguard combines precision fuel cell technology, ease of use and reliability into a consumer breathalyzer that stands above all others in personal use and in testing those you care about. The LifeGuard comes complete with a permanent (fold-away) mouthpiece, 10 disposable (slip-on) mouthpieces, 9V battery, wrist strap, nylon carry pouch, hard carry case, operations manual, and one year warranty.
The Precision Hand Held Reader Drug Test Cassette is a fast visual, competitive panel immunoassay that can be used for the qualitative detection of drug metabolites at specific cutoff levels in human Saliva Up to 99% Accurate Immediate Results Shelf-life up to 18 months Collect the specimen with collector Read the results immediately Ideal for low-volume donations These drug tests are intended for workplace testing & forensic use ONLY (not FDA cleared or CLIA waived).
The Discover Drug Test Cassette is a fast visual, competitive panel immunoassay that can be used for the qualitative detection of drug metabolites at specific cutoff levels in human Saliva Up to 99% Accurate Immediate Results Shelf-life up to 18 months Collect the specimen with collector Add 3 drops to the well Read the results immediately Ideal for low-volume donations These drug tests are intended for workplace testing & forensic use ONLY (not FDA cleared or CLIA waived).
CLIA Waived Use of this test with all authorized specimen types is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests. This test is also authorized for use with fingerstick whole blood specimens only at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. The CLIA Waived COVID-19 IgG/IgM Rapid Test Device is an in vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Emergency use of this test is limited to authorized laboratories. About Test Device EUA Authorized CE Mark Test does NOT give positive or negative result for COVID-19 virus. This is an antibody test, it only indicates past or recent infection. Read Results in 15 Minutes 9 Month Expiration from Date of Manufacture Contents 20 Test Devices 20 Disposable Pipettes 20 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
The CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within the first five days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., inpatient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. Lateral flow assay Detect SARS-CoV-2 nucleocapsid protein antigen Rapid results within 10-15 minutes Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation For use under the Emergency Use Authorization (EUA) only For in vitro diagnostic use only For prescription use only For use with direct anterior nasal and nasopharyngeal swab specimens Clinical Performance 93.75% PPAa and 99.32% NPAb when used with nasopharyngeal swab 87.18% PPAa and 100% NPAb when used with anterior nasal swab
Master Carton - Contains 625 Tests For International Sale Only - Call for Pricing The COVID-19 IgG/IgM Rapid Test Device is an in vitro Immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. About Test Device Gives Positive or Negative Result for COVID-19 IgM/IgG antibodies Read Results in 15 Minutes Contents of each box 25 Test Devices 25 Disposable Pipettes 25 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
PRICE PER TEST $8.99 TEST BinaxNOW COVID-19 Ag Card For Rapid Detection of SARS-CoV-2 | FDA EUA | IVD Use | RX Only The BinaxNOW COVID-19 Ag Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swabs from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset. Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in anterior nasal (nares) swabs during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Negative results should be treated as presumptive, do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. The BinaxNOW COVID-19 Ag Card is intended for use by medical professionals or trained operators who are proficient in performing rapid lateral flow tests. BinaxNOW COVID-19 Ag Card is only for use under the Food and Drug Administration's EUA. Kit Details Test Card: 40 cards with test strips Extraction Reagent: bottle containing 7.5 mL of extraction reagent Nasal swabs: 40 sterile, single use specimen sampling swabs Positive Control Swab: 1 each â??individually wrapped for single use Negative Control Swab: 1 each â??individually wrapped for single use Documentation: Product Insert, Procedure Card Performance Data Sensitivity: 97.1% Specificity: 98.5%
Our best selling fully automatic upper arm digital home blood pressure monitor. The 6021N features: Measures systolic, diastolic pressure, and pulse British Hypertension Society (BHS) AA rating ensures unrivaled accuracy Smart Logicâ?¢ Technology determines ideal inflation level Irregular Heartbeat detector Automatic inflation and deflation control Recalls last 99 readings with date and time stamp for two users Self-adjusting extended range latex-free D-Bar cuff fits arm ranges from 8.7 to 16.5 (22 cm to 42 cm) Auto-off Not made with natural rubber latex 4 AA batteries included Deluxe Storage case Optional AC adapter (sold separately) Meets or exceeds EN 1060-1, and EN 1060-3 5 Year Warranty
